Phase 2 Head and Neck Cancer Trial, Recruiting NCT06611137 Sponsor: Sun Yat-sen University Condition: Head and Neck Cancer
Back to Head And Neck Cancer

Phase 2 Head and Neck Cancer Trial, Recruiting

NCT06611137
Recruiting Phase 2

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People diagnosed with laryngeal (voice box) cancer at a specific stage (T3-4, N0-3, M0) or hypopharyngeal (lower throat) cancer at a specific stage (T2-4, N0-3, M0), as classified by the AJCC 8th edition staging system (confirm with trial site)
  • People aged between 18 and 70 years old
  • People with a performance status score of 0 or 1, meaning they are fully active or have only minor restrictions on physical activity (confirm with trial site)
  • People whose heart, kidney, liver, and blood functions are healthy enough to tolerate chemotherapy, immunotherapy, and radiation treatment

Who may not be able to join:

  • People who have been diagnosed with another type of cancer at the same time
  • People who have medical reasons why immunotherapy (a type of treatment that uses the body's immune system to fight cancer) would not be safe for them

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 12 July 2026
Phase 2: approximately ~30% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.
Phase success rates shown are historical industry-wide averages based on published data. They are not a prediction for this specific trial or your individual situation.

Contact this trial

Phone: +8613902205880

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Phase 2
Registry
ClinicalTrials.gov
Start date
11 September 2024
Est. completion
11 September 2025

Where this trial is recruiting

🇨🇳 China

Primary endpoints

objective response rate

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 12 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov